Jubilant Therapeutics Inc.

The BIOSECURE Act, when enacted, could leave some US pharma firms with pretty big shoes to fill given that it will strip the supply pool of WuXi AppTec Inc. , WuXi Biologics , Complete Genomics Inc

The US Food and Drug Administration (FDA) has had a significant influence on the direction Indian pharma companies’ revenues could head in a financial year given the dependence of these companies on N

The US Food and Drug Administration (FDA) has had a significant influence on the direction Indian pharma companies’ revenues could head in a financial year given the dependence of these companies on N

Merck & Co., Inc. is well aware that it needs to begin planning for its post-Keytruda future, with the blockbuster anti-PD-1 agent slated to lose patent protection in 2028, but with its plans for a l